Nutrien (NTR) Stock Forecast & Price Target

$52.58 +0.10 (+0.18%)

Closing price 03/24/2025 03:59 PM Eastern

Extended Trading

$52.62 +0.05 (+0.10%)

As of 03/24/2025 07:28 PM Eastern

Nutrien - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 16 Analyst Ratings

Sell
2

Hold
5

Buy
9

Based on 16 Wall Street analysts who have issued ratings for Nutrien in the last 12 months, the stock has a consensus rating of "Hold." Out of the 16 analysts, 2 have given a sell rating, 5 have given a hold rating, and 9 have given a buy rating for NTR.

Consensus Price Target

$60.13
14.36% Upside

According to the 16 analysts' twelve-month price targets for Nutrien, the average price target is $60.13. The highest price target for NTR is $75.00, while the lowest price target for NTR is $50.00. The average price target represents a forecasted upside of 14.36% from the current price of $52.58.

Get the Latest News and Ratings for NTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nutrien and its competitors.

NTR Analyst Ratings Over Time

Type	Current Forecast 3/25/24 to 3/25/25	1 Month Ago 2/24/24 to 2/23/25	3 Months Ago 12/26/23 to 12/25/24	1 Year Ago 3/26/23 to 3/25/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	10 Buy rating(s)	11 Buy rating(s)	11 Buy rating(s)
Hold	5 Hold rating(s)	6 Hold rating(s)	4 Hold rating(s)	7 Hold rating(s)
Sell	2 Sell rating(s)	1 Sell rating(s)	3 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$60.13	$59.39	$58.95	$69.80
Forecasted Upside	14.36% Upside	12.75% Upside	32.47% Upside	32.75% Upside
Consensus Rating	Hold	Moderate Buy	Hold	Hold

Remove Ads

NTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Nutrien Stock vs. The Competition

Type	Nutrien	Basic Materials Companies	S&P 500
Consensus Rating Score	2.44	2.77	2.54
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	14.36% Upside	138.62% Upside	16.92% Upside
News Sentiment Rating	Very Positive News See Recent NTR News	Positive News	Positive News

Remove Ads

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
3/13/2025	The Goldman Sachs Group 3 of 5 stars	A. Samuelson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Sell	$53.00	+4.44%
3/5/2025	Barclays 3 of 5 stars	B. Theurer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$56.00 ➝ $59.00	+20.08%
2/25/2025	CIBC 3 of 5 stars		Boost Target	Outperformer ➝ Outperformer	$64.00 ➝ $66.00	+24.22%
2/24/2025	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Wong Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$60.00 ➝ $60.00	+15.54%
2/24/2025	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ben Isaacson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Outperform ➝ Sector Outperform	$60.00 ➝ $62.00	+19.22%
2/21/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Garchitorena Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$53.00 ➝ $56.00	+4.53%
2/20/2025	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Christopher Parkinson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$52.00 ➝ $55.00	+3.55%
2/20/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Spector Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$53.00 ➝ $54.00	+0.30%
1/27/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Neivert Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$58.00 ➝ $63.00	+18.27%
1/13/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jeffrey Zekauskas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Neutral	$40.00 ➝ $50.00	+3.18%
Get the Latest News and Ratings for NTR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nutrien and its competitors with MarketBeat's FREE daily newsletter.
12/12/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$60.00	+25.31%
12/3/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Hansen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$58.00 ➝ $60.00	+25.63%
11/12/2024	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$63.00 ➝ $61.00	+29.32%
8/9/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$80.00 ➝ $75.00	+63.58%
8/2/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Seshadri Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Moderate Sell
8/2/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Hold ➝ Reduce
4/29/2024	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$60.00 ➝ $66.00	+25.59%
3/26/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$62.00	+17.92%
3/1/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$66.00	+26.36%
1/19/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$72.00 ➝ $75.00	+49.31%
11/30/2023	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral
7/25/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Equal Weight ➝ Equal Weight	$70.00	+5.69%
6/8/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$94.00 ➝ $85.00	+44.73%
5/11/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$70.00 ➝ $60.00	-5.30%
3/28/2023	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 07:25 AM ET.

Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, March 14, 2025. Please send any questions or comments about these Nutrien pros and cons to contact@marketbeat.com.

Nutrien
Bull Case

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

Nutrien Ltd. has a strong market capitalization of $24.51 billion, indicating a solid position in the agricultural sector, which can provide stability and growth potential for investors.
The stock is currently priced at $50.10, which is below the average target price of $60.13 set by analysts, suggesting potential for price appreciation.
Recent analyst upgrades, including a price target increase from CIBC to $66.00, reflect positive sentiment and confidence in the company's future performance.
Nutrien Ltd. has a dividend yield of 4.35%, providing investors with a steady income stream, which is particularly attractive in a low-interest-rate environment.
The company operates through multiple segments, including Retail, Potash, Nitrogen, and Phosphate, diversifying its revenue sources and reducing risk associated with reliance on a single market.

Nutrien
Bear Case

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

The company reported earnings per share of $0.28, missing analysts' expectations of $0.37, which may raise concerns about its profitability and operational efficiency.
Nutrien Ltd. has a high payout ratio of 159.12%, indicating that it is paying out more in dividends than it is earning, which could be unsustainable in the long run.
Two analysts have rated the stock with a sell rating, suggesting that there are significant concerns about its future performance that investors should consider.
The company has a net margin of only 2.62%, which is relatively low and may indicate challenges in managing costs and generating profit.
Recent revenue figures of $5.08 billion fell short of analyst estimates, which could signal potential difficulties in meeting market expectations moving forward.

NTR Forecast - Frequently Asked Questions

: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Nutrien is $60.13, with a high forecast of $75.00 and a low forecast of $50.00.
: 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 2 sell ratings, 5 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NTR, but not buy additional shares or sell existing shares.
: According to analysts, Nutrien's stock has a predicted upside of 14.36% based on their 12-month stock forecasts.
: Over the previous 90 days, Nutrien's stock had 2 upgrades by analysts.
: Nutrien has been rated by research analysts at Barclays, CIBC, JPMorgan Chase & Co., Mizuho, Piper Sandler, Royal Bank of Canada, Scotiabank, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Nutrien less than other "basic materials" companies. The consensus rating for Nutrien is Hold while the average consensus rating for "basic materials" companies is Moderate Buy. Learn more on how NTR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:NTR) was last updated on 3/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nutrien (NTR) Stock Forecast & Price Target